Try our Advanced Search for more refined results
Tevra Brands LLC v. Bayer HealthCare LLC, et al
Case Number:
5:19-cv-04312
See also:
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
May 01, 2024
Bayer Can't Scratch Off Antitrust Suit Over Flea, Tick Meds
A California federal judge has largely declined Bayer's bid to dismiss generics competitor Tevra's pet medication antitrust suit, saying in an order released Wednesday that there are factual disputes about whether Bayer's exclusivity deals with distributors and retailers significantly foreclosed Tevra's potential sales in the market.
-
May 03, 2021
Bayer Wants To Shake Off Flea & Tick Drugs Antitrust Suit
Bayer HealthCare LLC and a former subsidiary are seeking to escape pet medication company Tevra Brands LLC's $114 million antitrust suit for flea and tick treatment products, arguing that Tevra's proposed market argument is "fatally flawed because it fails to include all reasonably interchangeable products."
-
July 30, 2020
Bayer Antitrust Judge Fears Opening Discovery 'Floodgates'
A California federal judge expressed "a lot of concerns" Thursday about the adequacy of Tevra Brands LLC's $114 million pet medication antitrust complaint against Bayer, saying she's hesitant to "open up the floodgates of what will be enormously expensive discovery."
-
June 23, 2020
Bayer Foe Blocked From Serving Docs Via Email Amid Virus
A California federal judge overseeing a $114 million antitrust case against U.S.-based Bayer HealthCare LLC ruled Tuesday that the COVID-19 pandemic isn't enough reason to allow the generic pet medication company that brought the suit to serve Bayer's German parent company via email.
-
June 01, 2020
Bayer Slams Pet Med Co.'s Bid To Serve Docs Via Email
Bayer HealthCare urged a California federal court against allowing a generic pet medication maker to flout international protocol for how to serve documents in a $114 million antitrust case, saying the company is trying to use the COVID-19 pandemic as a scapegoat for its own delays and errors.
-
May 18, 2020
Bayer Foe Says Emailing Arnold & Porter Counts As Service
A California federal court has been urged to allow German-based Bayer AG and a subsidiary to be served documents for an antitrust suit over medication for fleas and ticks via email and through U.S.-based Bayer HealthCare LLC's attorneys at Arnold & Porter, due to service hiccups caused by the coronavirus pandemic.
-
April 06, 2020
Bayer Looks To Scratch Antitrust Suit Over Flea, Tick Med
Bayer HealthCare has urged a California federal judge to jettison a competitor's antitrust suit, saying the action can't prove Bayer unlawfully dominated sales of a topical flea and tick medication through exclusivity deals, because the arrangements don't lock rivals out of the market.